274 related articles for article (PubMed ID: 9788592)
1. Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia.
Esteller M; Corn PG; Urena JM; Gabrielson E; Baylin SB; Herman JG
Cancer Res; 1998 Oct; 58(20):4515-8. PubMed ID: 9788592
[TBL] [Abstract][Full Text] [Related]
2. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide.
Lin X; Asgari K; Putzi MJ; Gage WR; Yu X; Cornblatt BS; Kumar A; Piantadosi S; DeWeese TL; De Marzo AM; Nelson WG
Cancer Res; 2001 Dec; 61(24):8611-6. PubMed ID: 11751372
[TBL] [Abstract][Full Text] [Related]
3. I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma.
Jerónimo C; Varzim G; Henrique R; Oliveira J; Bento MJ; Silva C; Lopes C; Sidransky D
Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):445-50. PubMed ID: 12010858
[TBL] [Abstract][Full Text] [Related]
4. Silencing and CpG island methylation of GSTP1 is rare in ordinary gastric carcinomas but common in Epstein-Barr virus-associated gastric carcinomas.
Kim J; Lee HS; Bae SI; Lee YM; Kim WH
Anticancer Res; 2005; 25(6B):4013-9. PubMed ID: 16309193
[TBL] [Abstract][Full Text] [Related]
5. Silencing of pi-class glutathione S-transferase in MDA PCa 2a and MDA PCa 2b cells.
Vidanes GM; Paton V; Wallen E; Peehl DM; Navone N; Brooks JD
Prostate; 2002 Jun; 51(4):225-30. PubMed ID: 11987150
[TBL] [Abstract][Full Text] [Related]
6. Molecular detection of prostate cancer in urine by GSTP1 hypermethylation.
Cairns P; Esteller M; Herman JG; Schoenberg M; Jeronimo C; Sanchez-Cespedes M; Chow NH; Grasso M; Wu L; Westra WB; Sidransky D
Clin Cancer Res; 2001 Sep; 7(9):2727-30. PubMed ID: 11555585
[TBL] [Abstract][Full Text] [Related]
7. Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells.
Lin X; Nelson WG
Cancer Res; 2003 Jan; 63(2):498-504. PubMed ID: 12543808
[TBL] [Abstract][Full Text] [Related]
8. Detailed methylation analysis of the glutathione S-transferase pi (GSTP1) gene in prostate cancer.
Millar DS; Ow KK; Paul CL; Russell PJ; Molloy PL; Clark SJ
Oncogene; 1999 Feb; 18(6):1313-24. PubMed ID: 10022813
[TBL] [Abstract][Full Text] [Related]
9. Glutathione S-transferase pi (GSTP1) hypermethylation in prostate cancer: review 2007.
Meiers I; Shanks JH; Bostwick DG
Pathology; 2007 Jun; 39(3):299-304. PubMed ID: 17558856
[TBL] [Abstract][Full Text] [Related]
10. Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients.
Harden SV; Tokumaru Y; Westra WH; Goodman S; Ahrendt SA; Yang SC; Sidransky D
Clin Cancer Res; 2003 Apr; 9(4):1370-5. PubMed ID: 12684406
[TBL] [Abstract][Full Text] [Related]
11. CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia.
Brooks JD; Weinstein M; Lin X; Sun Y; Pin SS; Bova GS; Epstein JI; Isaacs WB; Nelson WG
Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):531-6. PubMed ID: 9641498
[TBL] [Abstract][Full Text] [Related]
12. Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1.
Nelson CP; Kidd LC; Sauvageot J; Isaacs WB; De Marzo AM; Groopman JD; Nelson WG; Kensler TW
Cancer Res; 2001 Jan; 61(1):103-9. PubMed ID: 11196146
[TBL] [Abstract][Full Text] [Related]
13. Glutathione S-transferase P1 and NADPH quinone oxidoreductase polymorphisms are associated with aberrant promoter methylation of P16(INK4a) and O(6)-methylguanine-DNA methyltransferase in sputum.
Gilliland FD; Harms HJ; Crowell RE; Li YF; Willink R; Belinsky SA
Cancer Res; 2002 Apr; 62(8):2248-52. PubMed ID: 11956078
[TBL] [Abstract][Full Text] [Related]
14. Silencing of glutathione S-transferase P1 by promoter hypermethylation and its relationship to environmental chemical carcinogens in hepatocellular carcinoma.
Zhang YJ; Chen Y; Ahsan H; Lunn RM; Chen SY; Lee PH; Chen CJ; Santella RM
Cancer Lett; 2005 Apr; 221(2):135-43. PubMed ID: 15808399
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells.
Song JZ; Stirzaker C; Harrison J; Melki JR; Clark SJ
Oncogene; 2002 Feb; 21(7):1048-61. PubMed ID: 11850822
[TBL] [Abstract][Full Text] [Related]
16. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.
Zhong S; Tang MW; Yeo W; Liu C; Lo YM; Johnson PJ
Clin Cancer Res; 2002 Apr; 8(4):1087-92. PubMed ID: 11948118
[TBL] [Abstract][Full Text] [Related]
17. Aberrant promoter methylation of multiple genes in non-small cell lung cancers.
Zöchbauer-Müller S; Fong KM; Virmani AK; Geradts J; Gazdar AF; Minna JD
Cancer Res; 2001 Jan; 61(1):249-55. PubMed ID: 11196170
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of the CpG islands in the promoter region of the GSTP1 gene in prostate cancer: a useful diagnostic and prognostic marker?
Bernardini S; Miano R; Iori R; Finazzi-Agrò E; Palmieri G; Ballerini S; Angeloni C; Orlandi A; Bellincampi L; Cortese C; Federici G
Clin Chim Acta; 2004 Dec; 350(1-2):181-8. PubMed ID: 15530476
[TBL] [Abstract][Full Text] [Related]
19. Association of GSTP1 CpG islands hypermethylation with poor prognosis in human breast cancers.
Arai T; Miyoshi Y; Kim SJ; Taguchi T; Tamaki Y; Noguchi S
Breast Cancer Res Treat; 2006 Nov; 100(2):169-76. PubMed ID: 16791478
[TBL] [Abstract][Full Text] [Related]
20. Regulation of glutathione S-transferase P1-1 gene expression by NF-kappaB in tumor necrosis factor alpha-treated K562 leukemia cells.
Morceau F; Duvoix A; Delhalle S; Schnekenburger M; Dicato M; Diederich M
Biochem Pharmacol; 2004 Apr; 67(7):1227-38. PubMed ID: 15013838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]